Real-world evidence from Germany: representativeness analysis and mortality endpoint validation in electronic health record-derived oncology cohorts
Abstract Background High-quality real-world data (RWD) for oncology research remains limited in Germany despite significant clinical need. Electronic health record (EHR)-derived datasets offer potential to capture longitudinal clinical information, but their value depends on representativeness and d...
保存先:
| 主要な著者: | , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2026-01-01
|
| シリーズ: | BMC Cancer |
| 主題: | |
| オンライン・アクセス: | https://doi.org/10.1186/s12885-026-15548-8 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
